Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN-210669 vs Bimatoprost in Glaucoma or Ocular Hypertension
NCT01291108Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simenepag isopropyl in Primary Open Angle Glaucoma (POAG), ocular hypertension, sponsored by Allergan. Started Apr 2011; status: completed.
02
Drugs
simenepag isopropyl
03
Conditions
Primary Open Angle Glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01291108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291108.